🇺🇸 FDA

Intelligence · Clinical Pipeline

Teva Pharma Pipeline

All ClinicalTrials.gov programs at Teva Pharma — phase, modality, and trial IDs.

Programs
473

Quick answer

Teva Pharma has 473 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Fluticasone Propionate MDPI

    Teva Pharma GmbH

    Asthma

    phase 1 small molecule completed

    1 trial

  2. GMX1777

    Teva Pharma GmbH

    Solid Tumors and Lymphomas

    phase 1 small molecule terminated

    1 trial

  3. GX15-070MS

    Teva Pharma GmbH

    Chronic Lymphocytic Leukemia

    phase 1 small molecule completed

    1 trial

  4. Glimepiride 4 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  5. Glucophage® XR 750 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  6. Glyburide/Metformin 5 mg/500 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  7. Granisetron hydrochloride 1 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  8. Hydrocodone Bitartrate extended-release tablet

    Teva Pharma GmbH

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  9. Hydrocodone bitartrate extended-release tablet

    Teva Pharma GmbH

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  10. LBR-101 IV

    Teva Pharma GmbH

    Bioavailability and Pharmacokinetics

    phase 1 mab completed

    1 trial

  11. Lamotrigine

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  12. Lamotrigine 25 mg Chewable Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  13. Lansoprazole

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    3 trials

  14. Leflunomide 20 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  15. Levetiracetam

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    4 trials

  16. Lipegfilgrastim

    Teva Pharma GmbH

    Ewing Family of Tumors, Rhabdomyosarcoma

    phase 1 small molecule completed

    1 trial

  17. Losartan

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  18. Losartan potassium/Hydrochlorothiazide

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  19. Meloxicam 15 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  20. Metronidazole

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  21. Mirtazapine 15 mg (Orally Disintegrating) Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  22. Moexipril HCl/hydrochlorothiazide 15/25 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  23. Mycophenolate Mofetil

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    4 trials

  24. NP101

    Teva Pharma GmbH

    Compare Bioequivalence Patches Previously Used in the NP101-007 Study

    phase 1 small molecule completed

    1 trial

  25. Nevirapine

    Teva Pharma GmbH

    HIV-1

    phase 1 small molecule completed

    1 trial

  26. Norethindrone/Ethinyl Estradiol

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  27. Norethindrone/Ethinyl Estradiol

    Teva Pharma GmbH

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  28. Obatoclax mesylate (GX15-070MS)

    Teva Pharma GmbH

    Hematological Malignancies

    phase 1 small molecule completed

    1 trial

  29. Olanzapine Extended Release

    Teva Pharma GmbH

    Schizophrenia, Schizoaffective Disorder

    phase 1 small molecule completed

    1 trial

  30. Omacetaxine

    Teva Pharma GmbH

    Hematologic Tumors

    phase 1 small molecule completed

    1 trial

  31. Ondansetron

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  32. Oxcarbazepine

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  33. PROT-CL-NP101-015.01

    Teva Pharma GmbH

    Acute Migraine

    phase 1 small molecule completed

    1 trial

  34. Pantoprazole Sodium 40 mg delayed-release tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  35. Paroxetine HCl

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  36. Pramipexole Dihydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  37. Pravastatin sodium 80 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  38. Progesterone vaginal ring,

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  39. Ramipril 10 mg capsule

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    3 trials

  40. Reslizumab IV

    Teva Pharma GmbH

    Absolute Bioavailability

    phase 1 small molecule completed

    1 trial

  41. Ribavirin 200 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  42. Risperidone

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  43. Ropinirole HCl 0.25 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  44. Rowasa® 4 gm/60 mL Rectal Enema

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  45. SD-809

    Teva Pharma GmbH

    TOURETTE SYNDROME

    phase 1 small molecule completed

    1 trial

  46. Sublingual Tizanidine HCl

    Teva Pharma GmbH

    Traumatic Brain Injury

    phase 1 small molecule completed

    1 trial

  47. Sumatriptan succinate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    3 trials

  48. Sumatriptan succinate

    Teva Pharma GmbH

    Migraine Disorders

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Teva Pharma have?

473 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.